N-(6-Bromo-3-(2-chloro-5-fluorophenyl)-2-(4-methoxybenzyl)-1-oxoisoindolin-4-yl)-3-fluoro-5-(trifluoromethyl)benzamide

Catalog No. :
ACJRZP740
CAS No. :
2734770-45-5
Molecular Formula :
C30H19BrClF5N2O3
Molecular Weight :
665.84

IUPAC Name:N-(6-bromo-3-(2-chloro-5-fluorophenyl)-2-(4-methoxybenzyl)-1-oxoisoindolin-4-yl)-3-fluoro-5-(trifluoromethyl)benzamide

N-(6-Bromo-3-(2-chloro-5-fluorophenyl)-2-(4-methoxybenzyl)-1-oxoisoindolin-4-yl)-3-fluoro-5-(trifluoromethyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(6-Bromo-3-(2-chloro-5-fluorophenyl)-2-(4-methoxybenzyl)-1-oxoisoindolin-4-yl)-3-fluoro-5-(trifluoromethyl)benzamide
IUPAC NameN-(6-bromo-3-(2-chloro-5-fluorophenyl)-2-(4-methoxybenzyl)-1-oxoisoindolin-4-yl)-3-fluoro-5-(trifluoromethyl)benzamide
Molecular FormulaC30H19BrClF5N2O3
Molecular Weight665.84
SMILESCOC1=CC=C(CN2C(=O)C3=C(C(NC(=O)C4=CC(C(F)(F)F)=CC(F)=C4)=CC(Br)=C3)C2C2=CC(F)=CC=C2Cl)C=C1
InChI KeyMDWFNDDBXZOFTQ-UHFFFAOYSA-N
SynonymN-(6-bromo-3-(2-chloro-5-fluorophenyl)-2-(4-methoxybenzyl)-1-oxoisoindolin-4-yl)-3-fluoro-5-(trifluoromethyl)benzamide
CAS No.2734770-45-5

Synthetic Route by SureRoute

1. ACJRZP740 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCLFQ657 route compound structure diagram
    ACCLFQ657171243-30-4 In Stock
  4. Then
  5. ACJRZP740 route product structure diagram
    ACJRZP7402734770-45-5
Inquiry

2. ACJRZP740 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLOYZ983 route compound structure diagram
    ACLOYZ983161622-05-5 In Stock
  4. Then
  5. ACJRZP740 route product structure diagram
    ACJRZP7402734770-45-5
Inquiry

Comments (0)